Since the introduction of transcatheter aortic valve implantation (TAVI) as a treatment for inoperable patients with aortic stenosis >1 decade ago, the range of patients who can benefit from this technology has continued to grow. In this Review, Jones and colleagues discuss the current evidence for TAVI in different patient populations, and describe the differences in design features in currently available valve systems.
- Brandon M. Jones
- Amar Krishnaswamy
- Samir R. Kapadia
